International Validation of a Sexual Quality of Life Questionnaire Specific to HIV and Hepatitis C (PROQOL-SexLife)

CompletedOBSERVATIONAL
Enrollment

1,164

Participants

Timeline

Start Date

February 20, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

June 30, 2020

Conditions
Sexual DysfunctionHIVHepatitis C
Trial Locations (17)

2006

University of Sydney, Sydney

13003

Hôpital Européen de Marseille, Marseille

21000

CHU de Dijon, Dijon

33604

CHU de Bordeaux, Bordeaux

44093

CHU Nantes, Nantes

44600

CH de Saint-Nazaire, Saint-Nazaire

75004

Hôpital Hôtel-Dieu, Paris

75010

Hôpital Lariboisière, Paris

75014

Institut Mutual Montsouris, Paris

75015

Hôpital Necker, Paris

78100

CHI Saint Germain en Laye, Saint-Germain-en-Laye

92150

Hôpital Foch, Suresnes

94275

Hôpital de Bicêtre, Le Kremlin-Bicêtre

94804

Centre Hépato -Biliaire de l'Hôpital Paul Brousse, Villejuif

04121-000

Center of treatment HIV/Aids - Brazil, São Paulo

Unknown

Clinique m&dicale L'Actuel, Montreal

31059 cedex 9

CHU Purpan, Toulouse

All Listed Sponsors
collaborator

University of Sydney

OTHER

collaborator

Center of treatment HIV/Aids-São Paulo

UNKNOWN

collaborator

Université de Montréal

OTHER

lead

University Paris 7 - Denis Diderot

OTHER

NCT03468673 - International Validation of a Sexual Quality of Life Questionnaire Specific to HIV and Hepatitis C (PROQOL-SexLife) | Biotech Hunter | Biotech Hunter